Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch.
Chickens were vaccinated with the herpesvirus of turkeys (HVT) at embryonation day 17 or 18 or at hatch and various responses of the 2 vaccinated groups were compared. In embryo-vaccinated chickens, HVT titers were high in the lungs before HVT could be isolated from other tissues. Seemingly, embryos acquired infection via the respiratory tract. In hatch-vaccinated chickens, HVT was first isolated from spleen and then from other tissues. Titers of recoverable HVT in tissues of embryo-vaccinated chickens were higher than in those of hatch-vaccinated chickens, particularly during the 1st week of age. Anti-HVT antibodies and natural killer cell reactivity in spleen effector cells were comparably increased in both vaccinated groups. Embryo vaccination with HVT did not cause progressive lesions, reduction in body weight gain, or impairment of humoral and cellular immune functions. Seemingly, HVT can be used safely as an embryonal vaccine in chickens.